InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Tregoning Kathleen. Director active across 2 companies, notably Spero Therapeutics, Inc.. Cumulatively, 7 reports have been logged. History available since 15 September 2022. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Tregoning Kathleen is a declarant associated with Spero Therapeutics, Inc., where the listed role is Director, and with Cerevel Therapeutics Holdings, Inc., where the listed role is See Remarks. She has 7 filings in total, and in the sampled recent filings covering the period from 2022-09-19 to 2025-06-16, both buy and sell amounts are 0 EUR, with Attribution as the modal transaction nature.